Success Stories
Strategic Diligence
Our Mission:
Clarify the worldwide opportunity for a pulmonary pharmaceutical platform technology.
Our Solution:
Worldwide preclinical and clinical development plans, registration
plans, and market valuations were developed, validated, and
integrated into a comprehensive, multiscenario valuation model
that estimated program value, share price, and earnings dilution.
The drug's basic science was completely reviewed, and 32 product
opportunities addressing 10 key indications were described
and confirmed. In-depth interviews with front-line clinicians,
thought leaders, and reimbursement and regulatory officials
were executed throughout the U.S., Canada, Japan, and major
European markets. The highest-value entry strategy was identified
with a trade-off analysis across indications, geographic markets,
and development risk.
Engagement Turnaround = 12 weeks.
Client Feedback:
"The analysis was extremely thorough and very professional…we
were delighted to be able to negotiate from a position of
knowing more about [the target’s] business than they
knew…we look forward to working together on the next
project."
Vice President, Development
Multinational Medical Products Firm
|
